Evidence map›Paper›PMID 28271077›Full record

ArticleJournal of immunology research2017

Olfa Khalifa, Nathalie Balandraud, Nathalie Lambert, Isabelle Auger, Jean Roudier, Audrey Sénéchal, David Geneviève, Christophe Picard, Gérard Lefranc, Isabelle Touitou and 8 more

Open access · goldAbstract read
In one paragraph

Article in Journal of immunology research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 2 countries.

Olfa KhalifaInserm, U 1183, Institute for Regenerative Medicine and Biotherapies, CHU Saint Eloi, 80 Avenue Augustin Fliche, 34295 Montpellier Cedex 5, France; University of Montpellier, Boulevard Henri IV, 34090 Montpellier, France.ORCID 0000-0001-5469-291X
Nathalie BalandraudInserm UMRs 1097, Aix-Marseille University, Marseille, France; Rheumatology Department, APHM, Marseille, France.ORCID 0000-0002-3839-0185
Nathalie LambertInserm UMRs 1097, Aix-Marseille University, Marseille, France.
Isabelle AugerInserm UMRs 1097, Aix-Marseille University, Marseille, France.
Jean RoudierInserm UMRs 1097, Aix-Marseille University, Marseille, France; Rheumatology Department, APHM, Marseille, France.
Audrey SénéchalInserm, U1051, University Hospital Saint Eloi, Institute for Neurosciences of Montpellier, Montpellier, France.
David GenevièveInserm, U 1183, Institute for Regenerative Medicine and Biotherapies, CHU Saint Eloi, 80 Avenue Augustin Fliche, 34295 Montpellier Cedex 5, France; University of Montpellier, Boulevard Henri IV, 34090 Montpellier, France; Department of Clinical Genetics, University Hospital of Montpellier, Montpellier, France.
Christophe PicardAix-Marseille University, CNRS, EFS, ADES UMR 7268, 13916 Marseille, France.ORCID 0000-0001-9118-5239
Gérard LefrancUniversity of Montpellier, Boulevard Henri IV, 34090 Montpellier, France; Laboratoire d'Immunogénétique Moléculaire, UPR 1142 CNRS, Institute of Human Genetics, Montpellier, France.
Isabelle TouitouInserm, U 1183, Institute for Regenerative Medicine and Biotherapies, CHU Saint Eloi, 80 Avenue Augustin Fliche, 34295 Montpellier Cedex 5, France; University of Montpellier, Boulevard Henri IV, 34090 Montpellier, France; Department of Molecular Genetics, University Hospital of Montpellier, France.ORCID 0000-0002-5171-1000
Bakridine M'Madi MrendaAix-Marseille University, CNRS, Centrale Marseille, I2M, UMR 7373, 13453 Marseille, France.
Cécilia BeneditoAix-Marseille University, CNRS, Centrale Marseille, I2M, UMR 7373, 13453 Marseille, France.
Etienne PardouxAix-Marseille University, CNRS, Centrale Marseille, I2M, UMR 7373, 13453 Marseille, France.
Anne-Laure GagezCNRS UMR 5235, Université de Montpellier, Montpellier, France.
Yves-Marie PersInserm, U 1183, Institute for Regenerative Medicine and Biotherapies, CHU Saint Eloi, 80 Avenue Augustin Fliche, 34295 Montpellier Cedex 5, France; University of Montpellier, Boulevard Henri IV, 34090 Montpellier, France; Clinical Department for Osteoarticular Diseases and Biotherapy, University Hospital Lapeyronie, 34295 Montpellier, France.ORCID 0000-0001-5927-3773
Christian JorgensenInserm, U 1183, Institute for Regenerative Medicine and Biotherapies, CHU Saint Eloi, 80 Avenue Augustin Fliche, 34295 Montpellier Cedex 5, France; University of Montpellier, Boulevard Henri IV, 34090 Montpellier, France; Clinical Department for Osteoarticular Diseases and Biotherapy, University Hospital Lapeyronie, 34295 Montpellier, France.
Touhami MahjoubLaboratory of Human Genome and Multifactorial Diseases, Faculty of Pharmacy, University of Monastir, Monastir, Tunisia.
Florence ApparaillyInserm, U 1183, Institute for Regenerative Medicine and Biotherapies, CHU Saint Eloi, 80 Avenue Augustin Fliche, 34295 Montpellier Cedex 5, France; University of Montpellier, Boulevard Henri IV, 34090 Montpellier, France; Clinical Department for Osteoarticular Diseases and Biotherapy, University Hospital Lapeyronie, 34295 Montpellier, France.ORCID 0000-0003-1762-084X
Inserm · FRCentre National de la Recherche Scientifique · FRUniversity of Monastir · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polymorphisms have been identified in the Xq28 locus as risk loci for rheumatoid arthritis (RA). Here, we investigated the association between three polymorphisms in the Xq28 region containing

Indexed as

Genetic Predisposition to DiseasePolymorphism, Single NucleotideAdultAgedAllelesArthritis, RheumatoidChromosomes, Human, XDisease SusceptibilityFemaleFranceGeographyHaplotypesHLA-DR AntigensHLA-DRB1 ChainsHumansInterleukin-1 Receptor-Associated KinasesHLA-DR AntigensHLA-DRB1 ChainsInterleukin-1 Receptor-Associated KinasesIRAK1 protein, humanMembrane ProteinsTMEM187 protein, human

Identifiers

PMID28271077
PMCPMC5320318
OpenAlexW2587733565

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.